Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing antibiotic use for uncomplicated urinary tract infection by treatment with Uva ursi
2016-000477-21Phase 3Completed
- Sponsor
- Georg-August-Universität Göttingen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atorvastatin in urinary tract infection (UTI) (2 arms), sponsored by Georg-August-Universität Göttingen. Primary endpoints: Antibiotic use reduction and Clinical safety and effectiveness. Started Jan 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2016-000477-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000477-21.